| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
Figure 3. FDG uptake in oesophageal cancer prior to and following therapy before surgical removal of the tumour. SUV decreases in the responding patient by over 70%, while SUV in the non-responder changes less than 30% [17].
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |